Uses
AG-012986 is a multitargeted CDK inhibitor. AG-012986 is active against CDK1/2/4/6/5/9, with Kis of 9.2 nM (CDK4/cyclin), 94 nM (CDK2/cyclin A), and 44 nM (CDK1/cyclin B), IC50s of 4 nM (CDK9/cyclin T) and 22 nM (CDK5/p35). AG-012986 has antiproliferative activities against cancer cells. AG-012986 induces cell cycle arrest, and apoptosis[1].
IC 50
Cdk1/cyclin B: 44 nM (Ki); cdk2/cyclin A: 94 nM (Ki); CDK4: 9.2 nM (Ki); CDK5/p35: 22 nM (IC
50); CDK9/Cyclin T: 4 nM (IC
50)